Plant Health Care - Notice of Results

Plant Health Care

12/04/2023 14:33

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230412:nRSL0126Wa&default-theme=true

RNS Number : 0126W  Plant Health Care PLC  12 April 2023

 

12 April 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Notice of Results

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel peptides for
plant protection to global agriculture markets, intends to publish its results
for the year ended 31 December 2022 on 2(nd) May 2023.

For further information, please contact:

 

 Plant Health Care plc                             Tel: +1 919 926 1600
 Jeff Tweedy, CEO
 Cenkos Securities plc - Nomad & Broker            Tel: +44 (0) 131 220 9771
 Neil McDonald / Pete Lynch
 SEC Newgate (Financial Communications)            Tel: +44 (0)7540 106 366
 Robin Tozer / George Esmond / Harry Handyside     Email: phc@secnewgate.co.uk (mailto:phc@secnewgate.co.uk)

 

 

About Plant Health Care plc

Plant Health Care offers products to improve the health, vigour and yield of
major field crops such as corn, soybeans, potatoes and rice, as well as
specialty crops such as fruits and vegetables. We operate globally through
subsidiaries, distributors and supply agreements with major industry partners.
Our innovative, patent-protected biological products help growers to protect
their crops from stress and diseases, and to produce higher quality fruit and
vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com (http://www.planthealthcare.com/)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFLFVVSFIFLIV